For years, patients with C3G and IC-MPGN had few options to stop the progression toward kidney failure. Now a new class of FDA-approved C3 inhibitors that targets the root of the complement system can ...

Our immune system works day and night to protect us from bacteria, viruses, and injuries. It is a complex defense network made up of many types of cells and proteins that cooperate to keep the body ...

Researchers have uncovered a potent genetic mechanism that could revolutionize cancer therapy. The immune system naturally generates a molecule known as IL-15, which serves as a defender that triggers ...

Commit Biologics, a biotech company pioneering complement system activation, has appointed Thomas Montgomery Andresen as Chief Executive Officer (CEO), effective 16 March 2026. Thomas, a biotech ...

Commit Biologics (“Commit”), a biotechnology company pioneering complement system activation and backed by €21.5 million in ...